Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Glucose-Lowering Drugs and Primary Prevention of Chronic Kidney Disease in Type 2 Diabetes Patients: A Real-World Primary Care Study.
Rodríguez-Miguel A, Fernández-Fernández B, Ortiz A, Gil M, Rodríguez-Martín S, Ruiz-Hurtado G, Fernández-Antón E, Ruilope LM, de Abajo FJ. Rodríguez-Miguel A, et al. Among authors: de abajo fj. Pharmaceuticals (Basel). 2024 Sep 29;17(10):1299. doi: 10.3390/ph17101299. Pharmaceuticals (Basel). 2024. PMID: 39458940 Free PMC article.
Understanding inconsistency in the results from observational pharmacoepidemiological studies: the case of antidepressant use and risk of hip/femur fractures.
Souverein PC, Abbing-Karahagopian V, Martin E, Huerta C, de Abajo F, Leufkens HG, Candore G, Alvarez Y, Slattery J, Miret M, Requena G, Gil MJ, Groenwold RH, Reynolds R, Schlienger RG, Logie JW, de Groot MC, Klungel OH, van Staa TP, Egberts TC, De Bruin ML, Gardarsdottir H. Souverein PC, et al. Pharmacoepidemiol Drug Saf. 2016 Mar;25 Suppl 1:88-102. doi: 10.1002/pds.3862. Pharmacoepidemiol Drug Saf. 2016. PMID: 27038355
Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project.
Huerta C, Abbing-Karahagopian V, Requena G, Oliva B, Alvarez Y, Gardarsdottir H, Miret M, Schneider C, Gil M, Souverein PC, De Bruin ML, Slattery J, De Groot MC, Hesse U, Rottenkolber M, Schmiedl S, Montero D, Bate A, Ruigomez A, García-Rodríguez LA, Johansson S, de Vries F, Schlienger RG, Reynolds RF, Klungel OH, de Abajo FJ. Huerta C, et al. Among authors: de groot mc, de vries f, de bruin ml, de abajo fj. Pharmacoepidemiol Drug Saf. 2016 Mar;25 Suppl 1:56-65. doi: 10.1002/pds.3825. Epub 2015 Jul 7. Pharmacoepidemiol Drug Saf. 2016. PMID: 26149383
157 results